US FDA panel backs Allos' lymphoma drug - Reuters

TopNews United StatesUS FDA panel backs Allos' lymphoma drugReutersO) experimental lymphoma drug Folotyn were not overwhelming but did look promising for a certain group of patients, a US medical advisory panel said on ...FDA panel backs Allos Therapeutics' cancer drugThe Associated PressFDA Advisory Committee Recommends Approval Of Allos Therapeutics ...RTT NewsAllos Cancer Drug Homers at FDA PanelTheStreet.comDenver Post -StreetInsider.com (subscription) -Visit Bulgariaall 141 news articles »